Tamoxifen-induced cirrhotic process.
Kotiloglu
G
G
Department of Internal Medicine, Bayindir Medical Center, Sogutozu/Ankara, Turkey.
Aki
Z S
ZS
Ozyilkan
O
O
Kutlay
L
L
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000150:complications* / Q000188:drug therapy* / Q000601:surgery; D018270:Carcinoma, Ductal, Breast / Q000150:complications* / Q000188:drug therapy* / Q000601:surgery; D005234:Fatty Liver / Q000150:complications*; D005260:Female; D042882:Gallstones / Q000150:complications; D006801:Humans; D008103:Liver Cirrhosis / Q000139:chemically induced* / Q000473:pathology; D008875:Middle Aged; D013629:Tamoxifen / Q000009:adverse effects*
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen